MedTrace Logo

The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer

NCT06033482 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-13

No results posted yet for this study

Summary

The main purpose of this study is to evaluate the reasonable range of No.12a lymph node dissection of locally advanced gastric cancer.

Conditions

Interventions

PROCEDURE

The reasonable range of No.12a lymph node dissection

The lymph node overlying the proper hepatic artery is defined as No.12aa. The lymph node overlying the left side of the portal vein is defined as No.12av. Observation of lymph node metastasis rates in two groups.

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • Bin Ke, MD · Department of Gastric cancer, Tianjin Medical University Cancer Institute & Hospital

  • Peng Ru Zhang, MD · Department of Gastric cancer, Tianjin Medical University Cancer Institute & Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-07-01
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06033482 on ClinicalTrials.gov